Skip to main content
Quest Diagnostics

Characterization of CNVs Identified by Genetic Testing of Epilepsy

European Society of Human Genetics

ESHG 2023

Glasgow, Scotland, UK, June 10-13, 2023

Poster presentation: Characterization of CNVs identified by genetic testing of epilepsy

Authors: Koskinen L, Hathaway J, Alakurtti K,  Castell MS, Hagström Å,  Kuisma H, Gall K, Saarinen I, Muona M, Pietilä T, Djupsjöbacka J, Gentile M, Salmenperä P, Tuupanen S, Kangas-Kontio T, Kämpjärvi K, Seppälä EH, Paananen J, Myllykangas S, Koskenvuo J

Specialty: Genetics, Neurology

Disclaimer: One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.

Publication
Progressive Myoclonus Epilepsies-Residual Unsolved Cases Have Marked Genetic Heterogeneity Including Dolichol-Dependent Protein Glycosylation Pathway Genes
Publication
Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy
The Utility of Exome Sequencing for Neurodevelopmental Disorders at a Large Reference Laboratory
Audio Podcast
Growing as a Laboratory Partner

Related content

The Utility of Exome Sequencing for Neurodevelopmental Disorders at a Large Reference Laboratory
Publication
Progressive myoclonus epilepsy caused by a homozygous splicing variant of
Publication
Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.